Myocarditis as a rare, yet serious adverse event associated with immune checkpoint inhibitors in patients with non-small cell lung cancer: Case series from a large community-based cancer center

Mohamed Hendawi; Luke Peterson; Eyob Tadesse; Frank Wolf; Thomas Brown; Michael A Thompson; Aurora Internal Medicine Residents; Aurora Complex General Surgical Oncology Faculty

doi:10.1200/JCO.2021.39.15_suppl.e21047

Myocarditis as a rare, yet serious adverse event associated with immune checkpoint inhibitors in patients with non-small cell lung cancer: Case series from a large community-based cancer center

Mohamed Hendawi, Luke Peterson, Eyob Tadesse, Frank Wolf, Thomas Brown, Michael A Thompson, Aurora Internal Medicine Residents, Aurora Complex General Surgical Oncology Faculty

Advocate Aurora Health

Research output: Contribution to journal › Meeting abstract

Original language	American English
Journal	Journal of Clinical Oncology
DOIs	https://doi.org/10.1200/JCO.2021.39.15_suppl.e21047
Status	Published - May 1 2021

Access to Document

10.1200/JCO.2021.39.15_suppl.e21047License: Unspecified

https://aurorahealthcare.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8NAEF6rD0UQj6p4lgGhTz2T5qiKoNEqSmmRWvoWNskWQ9tUmvQh_96ZbHooPkghD4HM7g7Mx8xO5mJMVcrV0i-dYLhVhxvC1U3TQwNh4rXd1bhnqJo74EJQcXL_zXx41t97jfsM0_4O6KNEK69WG706pYbOermm2SHNviwLhToOoCKm9nnksn9Yi1BC3ZRTNg1VKSF--0kDVcXAa6WmZdnVP_ZdMVkrtqe5tyab-2w3vWzCvUTHAcuIIMeyrTScnmOFjmxcHRehu6zDCotQgM6ypXV8uJG5HfPp8K4Vo-VDREV-CBwfQE9b3FaSb0WQNLGIgGA9mSEBTXsOBSRdonCFRILwgP7-gk-lKQIQNe7wa-IjhR98-o5P83_wFdKWr6GkDiZBelJJHhSO-WgEFHiAEWoscAm_05TmOuXGQiOdsCNCoEoa5HlEue_gysKYKP65KRl1L90KKHF1seMRu2k-da2X0lxI9pds1GGTg6NQtM5q2yQMW23Yc2HYUhjqMdvhVEsQREnNoXfCwDGrKmqmgd7QG3VU_9zxXFMfODXHUByT66esvs5RZ-stO2fb9IUyFpTqBduKpjNxyfb4bErmaJEkmGeb7d5jPsH-N3MSDPg

Cite this

Hendawi, M., Peterson, L., Tadesse, E., Wolf, F., Brown, T., Thompson, M. A., Internal Medicine Residents, A., & Complex General Surgical Oncology Faculty, A. (2021). Myocarditis as a rare, yet serious adverse event associated with immune checkpoint inhibitors in patients with non-small cell lung cancer: Case series from a large community-based cancer center. Journal of Clinical Oncology. https://doi.org/10.1200/JCO.2021.39.15_suppl.e21047

Hendawi, M, Peterson, L, Tadesse, E, Wolf, F, Brown, T, Thompson, MA, Internal Medicine Residents, A & Complex General Surgical Oncology Faculty, A 2021, 'Myocarditis as a rare, yet serious adverse event associated with immune checkpoint inhibitors in patients with non-small cell lung cancer: Case series from a large community-based cancer center', Journal of Clinical Oncology. https://doi.org/10.1200/JCO.2021.39.15_suppl.e21047

@article{d4d02255c586448abe9d823e084327bd,

title = "Myocarditis as a rare, yet serious adverse event associated with immune checkpoint inhibitors in patients with non-small cell lung cancer: Case series from a large community-based cancer center",

author = "Mohamed Hendawi and Luke Peterson and Eyob Tadesse and Frank Wolf and Thomas Brown and Thompson, {Michael A} and {Internal Medicine Residents}, Aurora and {Complex General Surgical Oncology Faculty}, Aurora",

note = "Hendawi M, Peterson L, Tadesse Ea, et al. Myocarditis as a rare, yet serious adverse event associated with immune checkpoint inhibitors in patients with non-small cell lung cancer: Case series from a large community-based cancer center. Journal of clinical oncology. 2021;39:e21047-e21047.",

year = "2021",

month = may,

day = "1",

doi = "10.1200/JCO.2021.39.15_suppl.e21047",

language = "American English",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - Myocarditis as a rare, yet serious adverse event associated with immune checkpoint inhibitors in patients with non-small cell lung cancer: Case series from a large community-based cancer center

AU - Hendawi, Mohamed

AU - Peterson, Luke

AU - Tadesse, Eyob

AU - Wolf, Frank

AU - Brown, Thomas

AU - Thompson, Michael A

AU - Internal Medicine Residents, Aurora

AU - Complex General Surgical Oncology Faculty, Aurora

N1 - Hendawi M, Peterson L, Tadesse Ea, et al. Myocarditis as a rare, yet serious adverse event associated with immune checkpoint inhibitors in patients with non-small cell lung cancer: Case series from a large community-based cancer center. Journal of clinical oncology. 2021;39:e21047-e21047.

PY - 2021/5/1

Y1 - 2021/5/1

UR - https://institutionalrepository.aah.org/medicineresidents/64

UR - https://aurorahealthcare.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8NAEF6rD0UQj6p4lgGhTz2T5qiKoNEqSmmRWvoWNskWQ9tUmvQh_96ZbHooPkghD4HM7g7Mx8xO5mJMVcrV0i-dYLhVhxvC1U3TQwNh4rXd1bhnqJo74EJQcXL_zXx41t97jfsM0_4O6KNEK69WG706pYbOermm2SHNviwLhToOoCKm9nnksn9Yi1BC3ZRTNg1VKSF--0kDVcXAa6WmZdnVP_ZdMVkrtqe5tyab-2w3vWzCvUTHAcuIIMeyrTScnmOFjmxcHRehu6zDCotQgM6ypXV8uJG5HfPp8K4Vo-VDREV-CBwfQE9b3FaSb0WQNLGIgGA9mSEBTXsOBSRdonCFRILwgP7-gk-lKQIQNe7wa-IjhR98-o5P83_wFdKWr6GkDiZBelJJHhSO-WgEFHiAEWoscAm_05TmOuXGQiOdsCNCoEoa5HlEue_gysKYKP65KRl1L90KKHF1seMRu2k-da2X0lxI9pds1GGTg6NQtM5q2yQMW23Yc2HYUhjqMdvhVEsQREnNoXfCwDGrKmqmgd7QG3VU_9zxXFMfODXHUByT66esvs5RZ-stO2fb9IUyFpTqBduKpjNxyfb4bErmaJEkmGeb7d5jPsH-N3MSDPg

U2 - 10.1200/JCO.2021.39.15_suppl.e21047

DO - 10.1200/JCO.2021.39.15_suppl.e21047

M3 - Meeting abstract

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Myocarditis as a rare, yet serious adverse event associated with immune checkpoint inhibitors in patients with non-small cell lung cancer: Case series from a large community-based cancer center

Access to Document

Other files and links

Cite this